| Issue Date | Title | Author(s) |
| 2017-09-01 | Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality | Tran, T; Bliuc, D; van Geel, T; Adachi, JD; Berger, C; van den Bergh, J; Eisman, JA; Geusens, P; Goltzman, D; Hanley, DA; Josse, RG; Kaiser, SM; Kovacs, CS; Langsetmo, L; Prior, JC; Nguyen, TV; Center, JR |
| 2021-02 | Assessing the clinical utility of genetic profiling in fracture risk prediction: a decision curve analysis. | Ho-Le, TP; Tran, HTT; Center, JR; Eisman, JA; Nguyen, HT; Nguyen, TV |
| 2015-09 | The biological response to nanometre-sized polymer particles. | Liu, A; Richards, L; Bladen, CL; Ingham, E; Fisher, J; Tipper, JL |
| 2022-04-01 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | Araujo, AM; Abaurrea, A; Azcoaga, P; López-Velazco, JI; Manzano, S; Rodriguez, J; Rezola, R; Egia-Mendikute, L; Valdés-Mora, F; Flores, JM; Jenkins, L; Pulido, L; Osorio-Querejeta, I; Fernández-Nogueira, P; Ferrari, N; Viera, C; Martín-Martín, N; Tzankov, A; Eppenberger-Castori, S; Alvarez-Lopez, I; Urruticoechea, A; Bragado, P; Coleman, N; Palazón, A; Carracedo, A; Gallego-Ortega, D; Calvo, F; Isacke, CM; Caffarel, MM; Lawrie, CH |
| 2013-04 | Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. | Lee, HJ; Gallego-Ortega, D; Ledger, A; Schramek, D; Joshi, P; Szwarc, MM; Cho, C; Lydon, JP; Khokha, R; Penninger, JM; Ormandy, CJ |
| 2013-05-23 | Functional characterization of cancer-associated Gab1 mutations. | Ortiz-Padilla, C; Gallego-Ortega, D; Browne, BC; Hochgräfe, F; Caldon, CE; Lyons, RJ; Croucher, DR; Rickwood, D; Ormandy, CJ; Brummer, T; Daly, RJ |
| 2022-10-03 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | Araujo, AM; Abaurrea, A; Azcoaga, P; López-Velazco, JI; Manzano, S; Rodriguez, J; Rezola, R; Egia-Mendikute, L; Valdés-Mora, F; Flores, JM; Jenkins, L; Pulido, L; Osorio-Querejeta, I; Fernández-Nogueira, P; Ferrari, N; Viera, C; Martín-Martín, N; Tzankov, A; Eppenberger-Castori, S; Alvarez-Lopez, I; Urruticoechea, A; Bragado, P; Coleman, N; Palazón, A; Carracedo, A; Gallego-Ortega, D; Calvo, F; Isacke, CM; Caffarel, MM; Lawrie, CH |
| 2015-11-16 | Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms. | Di Bartolo, BA; Cartland, SP; Prado-Lourenco, L; Griffith, TS; Gentile, C; Ravindran, J; Azahri, NSM; Thai, T; Yeung, AWS; Thomas, SR; Kavurma, MM |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2011-10 | Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. | Lee, HJ; Hinshelwood, RA; Bouras, T; Gallego-Ortega, D; Valdés-Mora, F; Blazek, K; Visvader, JE; Clark, SJ; Ormandy, CJ |
